The purpose of this study is to evaluate the effectiveness of High Frequency (10kHz) Spinal Cord Stimulation in patients with chronic Chemotherapy-Induced Peripheral Neuropathy

CONDITION

Cancer

GENDER

Both males and females

AGE GROUP

From 18

to 100 years

STATUS

Recruiting

  • Aims: to document the efficacy and safety outcomes of SCS in persons with chronic, chemotherapy-induced peripheral neuropathy
  • Types of chemotherapy: Taxotere, Oxaliplatin, Paclitaxel
  • Primary outcome measure: % responder rate at six months
  • Number of participants: 20-25
  • Follow-up: 12 months

CONTACT DETAILS

Clinical Trial Site: Sydney Pain Research Centre
Phone Number: 0481130352 Email: research@sydneypaincentre.com Location: 214 172 fox Vally Road

Studies Contact Form

  • Hidden

Approved By: Bellberry Limited              

Clinical Trial Registry Link: